4/4
03:22 pm
tndm
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Medium
Report
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness [Yahoo! Finance]
4/2
04:05 pm
tndm
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
Medium
Report
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
3/27
09:00 am
tndm
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm
Medium
Report
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm
3/22
02:18 pm
tndm
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch [Yahoo! Finance]
Low
Report
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch [Yahoo! Finance]
3/19
08:00 am
tndm
Tandem Diabetes Care (TNDM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $35.00 price target on the stock, up from $27.00.
Low
Report
Tandem Diabetes Care (TNDM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $35.00 price target on the stock, up from $27.00.
3/17
08:00 am
tndm
Tandem Diabetes Care (TNDM) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $33.00 price target on the stock.
Medium
Report
Tandem Diabetes Care (TNDM) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $33.00 price target on the stock.
3/16
06:39 am
tndm
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges [Yahoo! Finance]
Low
Report
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges [Yahoo! Finance]
3/15
10:29 am
tndm
Assessing Tandem Diabetes Care (TNDM) Valuation After Android Expansion For Tandem Mobi [Yahoo! Finance]
Low
Report
Assessing Tandem Diabetes Care (TNDM) Valuation After Android Expansion For Tandem Mobi [Yahoo! Finance]
3/15
03:17 am
tndm
How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones [Yahoo! Finance]
3/15
02:22 am
tndm
Tandem Diabetes Android Launch Expands Access And Shapes TNDM Valuation Story [Yahoo! Finance]
Low
Report
Tandem Diabetes Android Launch Expands Access And Shapes TNDM Valuation Story [Yahoo! Finance]
3/4
11:55 pm
tndm
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story [Yahoo! Finance]
Low
Report
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story [Yahoo! Finance]
3/4
05:22 pm
tndm
Tandem Mobi Now Compatible with Android Smartphones [Yahoo! Finance]
Medium
Report
Tandem Mobi Now Compatible with Android Smartphones [Yahoo! Finance]
3/4
05:00 pm
tndm
Tandem Mobi Now Compatible with Android Smartphones
Medium
Report
Tandem Mobi Now Compatible with Android Smartphones
3/3
10:03 am
tndm
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
Low
Report
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
3/2
12:36 pm
tndm
Tandem Diabetes Care (TNDM) had its price target raised by Morgan Stanley from $23.00 to $25.00. They now have an "equal weight" rating on the stock.
Low
Report
Tandem Diabetes Care (TNDM) had its price target raised by Morgan Stanley from $23.00 to $25.00. They now have an "equal weight" rating on the stock.
3/1
11:56 pm
tndm
Tandem Diabetes Care Conference: Record 58% Margin, “Toby” Tubeless Mobi and Pharmacy Shift Ahead [Yahoo! Finance]
Low
Report
Tandem Diabetes Care Conference: Record 58% Margin, “Toby” Tubeless Mobi and Pharmacy Shift Ahead [Yahoo! Finance]
2/25
12:30 am
tndm
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
Low
Report
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
2/23
04:05 pm
tndm
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Low
Report
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
2/23
12:05 pm
tndm
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
Medium
Report
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
2/23
08:59 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
2/23
08:03 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
2/23
07:17 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/23
07:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/20
10:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
2/20
09:36 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.